Opioid-induced constipation (OIC) is a common side effect experienced by patients who take opioid medications for pain management. Opioids bind to receptors in the gastrointestinal tract, slowing down bowel movements and leading to constipation. To address this issue, specific drugs have been developed to target OIC and provide relief to patients. The global opioid induced constipation (OIC) drugs market was valued at $1105.71 million in 2021, and is projected to reach $1785.01 million by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
♦ Request Sample Copy of Report –
https://www.alliedmarketresearch.com/request-sample/13745
One class of drugs used to manage OIC is known as peripherally acting mu-opioid receptor antagonists (PAMORAs). These medications, such as naloxegol and methylnaltrexone, work by selectively blocking opioid receptors in the gut without affecting pain relief in other areas. By reversing the constipating effects of opioids, PAMORAs help restore normal bowel function and alleviate OIC symptoms.
Major market players covered in the report, such as –
• AstraZeneca plc,
• cosmo pharmaceuticals,
• Dr. Reddy’s Laboratories Ltd.,
• Mallinckrodt plc,
• Novartis AG,
• Teva Pharmaceutical Industries Ltd.,
• Shionogi & Co., Ltd.,
• Bausch Health Companies Inc.,
• Merck & Co., Inc.,
• Takeda Pharmaceutical Company Limited
♦ Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures) @
https://www.alliedmarketresearch.com/opioid-induced-constipation-oic-drugs-market/purchase-options
Key Benefits for Stakeholders –
• The report provides quantitative analysis of market segments, current trends, strategies and potential of Opioid Induced Constipation (OIC) Drugs Market research to identify potential Opioid Induced Constipation (OIC) Drugs Market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided. • Porter’s Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global Opioid Induced Constipation (OIC) Drugs Market analysis, key players, market segments, application areas and Market growth strategies.
Another approach to managing OIC involves the use of stool softeners, laxatives, and bowel stimulants. These drugs, such as polyethylene glycol (PEG) and stimulant laxatives like bisacodyl, promote bowel movement by increasing water content in the intestines or stimulating the muscles in the gastrointestinal tract. They help soften the stool and relieve constipation caused by opioid use.
It is worth noting that the choice of OIC drug depends on factors such as the severity of constipation, individual patient characteristics, and the specific opioid being used. Healthcare providers work closely with patients to determine the most suitable treatment option and adjust medication regimens accordingly. Managing OIC effectively is crucial to ensure optimal pain management and improve the overall quality of life for patients taking opioids for chronic pain conditions.
♦ For Purchase Enquiry –
https://www.alliedmarketresearch.com/purchase-enquiry/13745
Frequently Asked Questions?
Q1. What is the total market value of Opioid Induced Constipation (OIC) Drugs Market report?
Q2. Which are the top companies holding the market share in Opioid Induced Constipation (OIC) Drugs Market?
Q3. Which are the largest regions for this Market?
Q4. What is the leading technology of Opioid Induced Constipation (OIC) Drugs Market?
Q5. What are the major drivers for this specific Market?
Q6. What are the upcoming key trends in the Opioid Induced Constipation (OIC) Drugs Market report?
Contact Us –
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
